Former ENT&A CEO Bob Glazer Joins Prosidio as Strategic Advisor to Enhance Endoscopy Accessibility

Prosidio, a surgical-visualization company dedicated to making premium endoscopy affordable for outpatient practices, has announced the addition of Robert (Bob) Glazer, former Chief Executive Officer of ENT and Allergy Associates (ENT&A), as a strategic advisor. Glazer's extensive experience in building and scaling physician practices is expected to significantly contribute to Prosidio's mission of delivering hospital-grade visualization tools to every exam room.

Jonathan Simmonds, MD, co-founder and CEO of Prosidio, highlighted Glazer's deep understanding of the challenges faced by private practices in balancing clinical excellence with financial constraints. Prosidio's innovative approach, which includes a suitcase-sized, chip-on-tip endoscopy platform, stands to benefit greatly from Glazer's insights into practice operations and market expansion strategies.

Glazer, who has followed Simmonds' career since his residency at Tufts, expressed enthusiasm for Prosidio's technology, particularly its ability to compress an entire endoscopy tower into a compact, 4K platform. He sees this as a game-changer for private practices seeking state-of-the-art alternatives at reasonable costs. Glazer's role will involve guiding the company's commercial strategy and fostering distribution partnerships to broaden the adoption of Prosidio's solutions.

Under Glazer's leadership, ENT&A expanded from 40 to over 300 physicians across 60 locations, setting operational benchmarks for private ENT practices. His expertise will be invaluable as Prosidio seeks to empower outpatient specialists with advanced, yet affordable, surgical visualization tools. This collaboration underscores Prosidio's commitment to enhancing patient care through innovative technology that is both accessible and effective.